174 related articles for article (PubMed ID: 16157195)
1. Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes.
Chan EC; Lam SY; Fu KH; Kwong YL
Cancer Genet Cytogenet; 2005 Oct; 162(1):10-20. PubMed ID: 16157195
[TBL] [Abstract][Full Text] [Related]
2. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum.
Gilliland FD; Harms HJ; Crowell RE; Li YF; Willink R; Belinsky SA
Cancer Res; 2002 Apr; 62(8):2248-52. PubMed ID: 11956078
[TBL] [Abstract][Full Text] [Related]
3. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation profiles of lung tumors.
Toyooka S; Toyooka KO; Maruyama R; Virmani AK; Girard L; Miyajima K; Harada K; Ariyoshi Y; Takahashi T; Sugio K; Brambilla E; Gilcrease M; Minna JD; Gazdar AF
Mol Cancer Ther; 2001 Nov; 1(1):61-7. PubMed ID: 12467239
[TBL] [Abstract][Full Text] [Related]
5. Association between polymorphisms in the XRCC1 and GST genes, and CpG island methylation status in colonic mucosa in ulcerative colitis.
Tahara T; Shibata T; Nakamura M; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Hirata I; Arisawa T
Virchows Arch; 2011 Feb; 458(2):205-11. PubMed ID: 21234761
[TBL] [Abstract][Full Text] [Related]
6. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer.
Toyooka S; Maruyama R; Toyooka KO; McLerran D; Feng Z; Fukuyama Y; Virmani AK; Zochbauer-Muller S; Tsukuda K; Sugio K; Shimizu N; Shimizu K; Lee H; Chen CY; Fong KM; Gilcrease M; Roth JA; Minna JD; Gazdar AF
Int J Cancer; 2003 Jan; 103(2):153-60. PubMed ID: 12455028
[TBL] [Abstract][Full Text] [Related]
7. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X
Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600
[TBL] [Abstract][Full Text] [Related]
8. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas.
Risch A; Wikman H; Thiel S; Schmezer P; Edler L; Drings P; Dienemann H; Kayser K; Schulz V; Spiegelhalder B; Bartsch H
Pharmacogenetics; 2001 Dec; 11(9):757-64. PubMed ID: 11740339
[TBL] [Abstract][Full Text] [Related]
9. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
[TBL] [Abstract][Full Text] [Related]
10. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.
Miller DP; Liu G; De Vivo I; Lynch TJ; Wain JC; Su L; Christiani DC
Cancer Res; 2002 May; 62(10):2819-23. PubMed ID: 12019159
[TBL] [Abstract][Full Text] [Related]
11. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
Harden SV; Tokumaru Y; Westra WH; Goodman S; Ahrendt SA; Yang SC; Sidransky D
Clin Cancer Res; 2003 Apr; 9(4):1370-5. PubMed ID: 12684406
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL
Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
[TBL] [Abstract][Full Text] [Related]
13. Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study.
Wang Y; Spitz MR; Schabath MB; Ali-Osman F; Mata H; Wu X
Lung Cancer; 2003 Apr; 40(1):25-32. PubMed ID: 12660004
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of cisplatin-based chemotherapy is associated with the polymorphisms of GSTP1 and XRCC1 in advanced non-small cell lung cancer patients.
Deng JH; Deng J; Shi DH; Ouyang XN; Niu PG
Clin Transl Oncol; 2015 Sep; 17(9):720-6. PubMed ID: 26033426
[TBL] [Abstract][Full Text] [Related]
15. Association between genetic polymorphisms in XPD and XRCC1 genes and risks of non-small cell lung cancer in East Chinese Han population.
Du Y; He Y; Mei Z; Qian L; Shi J; Jie Z
Clin Respir J; 2016 May; 10(3):311-7. PubMed ID: 25308691
[TBL] [Abstract][Full Text] [Related]
16. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
Singal R; Ferdinand L; Reis IM; Schlesselman JJ
Oncol Rep; 2004 Sep; 12(3):631-7. PubMed ID: 15289848
[TBL] [Abstract][Full Text] [Related]
17. Gene polymorphism of DNA repair gene X-ray repair cross complementing group 1 and xeroderma pigmentosum group D and environment interaction in non-small-cell lung cancer for Chinese nonsmoking female patients.
Wang L; Wang LL; Shang D; Yin SJ; Sun LL; Wang XY; Ji HB
Kaohsiung J Med Sci; 2019 Jan; 35(1):39-48. PubMed ID: 30844146
[TBL] [Abstract][Full Text] [Related]
18. Association of DNA repair and xenobiotic pathway gene polymorphisms with genetic susceptibility to gastric cancer patients in West Bengal, India.
Ghosh S; Ghosh S; Bankura B; Saha ML; Maji S; Ghatak S; Pattanayak AK; Sadhukhan S; Guha M; Nachimuthu SK; Panda CK; Maity B; Das M
Tumour Biol; 2016 Jul; 37(7):9139-49. PubMed ID: 26768611
[TBL] [Abstract][Full Text] [Related]
19. Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer.
Russo AL; Thiagalingam A; Pan H; Califano J; Cheng KH; Ponte JF; Chinnappan D; Nemani P; Sidransky D; Thiagalingam S
Clin Cancer Res; 2005 Apr; 11(7):2466-70. PubMed ID: 15814621
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase M1 and P1 metabolic polymorphism and lung cancer predisposition.
Reszka E; Wasowicz W; Rydzynski K; Szeszenia-Dabrowska N; Szymczak W
Neoplasma; 2003; 50(5):357-62. PubMed ID: 14628089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
